MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin (Q35091212)

6 August 2017

title

MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin (English)

1 reference

6 August 2017

10

Ruben Niesvizky

1 reference

6 August 2017

2

Achim A Jungbluth

1 reference

6 August 2017

15

Lloyd J Old

1 reference

6 August 2017

14

Nina Bhardwaj

1 reference

6 August 2017

Tricia Nardiello

1

1 reference

6 August 2017

Anna Mei

3

1 reference

6 August 2017

Maurizio Diliberto

4

1 reference

6 August 2017

Xiangao Huang

5

1 reference

6 August 2017

Ania Dabrowski

6

1 reference

6 August 2017

Valéria C C Andrade

7

1 reference

6 August 2017

Rebecca Wasserstrum

8

1 reference

6 August 2017

Scott Ely

9

1 reference

6 August 2017

Roger Pearse

11

1 reference

6 August 2017

Morton Coleman

12

1 reference

6 August 2017

David S Jayabalan

13

1 reference

6 August 2017

Selina Chen-Kiang

16

1 reference

6 August 2017

Hearn Jay Cho

17

1 reference

6 August 2017

language of work or name

English

0 references

publication date

12 May 2011

1 reference

6 August 2017

published in

Clinical Cancer Research

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

13

1 reference

6 August 2017

page(s)

4309-4319

1 reference

describes a project that uses

6 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3131419/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in patients with multiple myeloma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Cancer/testis antigens, gametogenesis and cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

An overview of the MAGE gene family with the identification of all human members of the family

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Control of apoptosis and mitotic spindle checkpoint by survivin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Structure, chromosomal localization, and expression of 12 genes of the MAGE family

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Clinical course of patients with relapsed multiple myeloma

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3131419

The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation

16 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21565982

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Telomerase activity in B-cell non-Hodgkin lymphoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21565982

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-10-1820

1 reference

6 August 2017

1 reference

6 August 2017

1 reference